SAR-CoV-2 originated from China with first case reporting from Wuhan, has been declared as pandemic by WHO on March 11 2020, which has affected millions of people around the globe with 213 countries and territories infected worldwide It has caused the death of around 0 6 million individuals with no specific or promising vaccines or treatment available until now to prevent COVID 19, which has been approved;this has led the world to a global crisis not only on the health front but also affected the economic sectors Researchers across the globe are working around the clock with their level best to discover promising therapeutic approaches for COVID 19, but till now for the treatment, only 3 therapeutics have been approved, including dexamethasone in U K and Japan, Avigan in Russia, Italy, and China and remdesivir in Japan and Australia;also convalescent plasma therapy is seen to be effective in critical cases of COVID-19, however, there are limitations with the use of this plasma therapy like the time point of treatment, optimal dose as the dose may vary with number of patients the particular therapeutic effects of convalescent plasma therapy will be further explored in randomized clinical trials Several complete multinational studies are investigating alternative therapies More than 100 countries entered a cooperation to evaluate applicants for high-profile COVID-19 diagnosis with this most massive WHO's cooperation According to WHO's information, there are 28 vaccine candidates under clinical evaluation, with 6 of them entering phase 3 This review emphasizes the allopathic approaches along with the Chinese herbal medicine for the prevention of COVID-19 This paper also includes a brief discussion on the vaccine and nutritional supplements © The Author(s), 2020
Therapeutic Approach for COVID-19 – Clinical Challenges and Implementation